MA39908A - Composition médicinale comprenant un composé pyrazine carboxamide utilisé comme principe actif - Google Patents
Composition médicinale comprenant un composé pyrazine carboxamide utilisé comme principe actifInfo
- Publication number
- MA39908A MA39908A MA039908A MA39908A MA39908A MA 39908 A MA39908 A MA 39908A MA 039908 A MA039908 A MA 039908A MA 39908 A MA39908 A MA 39908A MA 39908 A MA39908 A MA 39908A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibiting effect
- cancers
- jak3
- itk
- btk
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
Le problème décrit par la présente invention est de fournir une composition médicinale destinée à traiter un cancer dans lequel participe au moins une kinase choisie parmi la btk, la jak3 et l'itk. Suite aux résultats d'études sur des composés ayant un effet inhibiteur sur la btk, un effet inhibiteur sur la jak3 et un effet inhibiteur sur l'itk, les présents inventeurs ont confirmé que des composés pyrazine carboxamide spécifiques présentent un effet inhibiteur sur la btk, un effet inhibiteur sur la jak3 et un effet inhibiteur sur l'itk, et que des compositions médicinales comprenant ces composés utilisés comme principe actif présentent un effet thérapeutique sur des cancers dans lesquels participe au moins une kinase choisie parmi la btk, la jak3 et l'itk, des cancers dans lesquels la btk est surexprimée ou activée dans un autre mode de réalisation, des cancers dans lesquels sont activés des signaux de récepteurs de lymphocytes b dans encore un autre mode de réalisation, des cancers dans lesquels la jak3 a subi une mutation-activation dans encore un autre mode de réalisation, et des cancers dans lesquels l'itk est activée dans encore un autre mode de réalisation, achevant ainsi la présente invention.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014109952 | 2014-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39908A true MA39908A (fr) | 2015-12-03 |
Family
ID=54698952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA039908A MA39908A (fr) | 2014-05-28 | 2015-05-27 | Composition médicinale comprenant un composé pyrazine carboxamide utilisé comme principe actif |
Country Status (15)
Country | Link |
---|---|
US (1) | US20170196859A1 (fr) |
EP (1) | EP3150206A1 (fr) |
JP (1) | JPWO2015182628A1 (fr) |
KR (1) | KR20170005820A (fr) |
CN (1) | CN106456636A (fr) |
AU (1) | AU2015266552A1 (fr) |
CA (1) | CA2949028A1 (fr) |
EA (1) | EA201692479A1 (fr) |
IL (1) | IL249010A0 (fr) |
MA (1) | MA39908A (fr) |
MX (1) | MX2016015551A (fr) |
PH (1) | PH12016502313A1 (fr) |
SG (1) | SG11201609837WA (fr) |
TW (1) | TW201625254A (fr) |
WO (1) | WO2015182628A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3290036A4 (fr) * | 2015-04-27 | 2019-01-02 | Astellas Pharma Inc. | Composition pharmaceutique stabilisée |
JP2019014653A (ja) * | 2015-11-27 | 2019-01-31 | アステラス製薬株式会社 | がん免疫を介したがん治療方法 |
US20190282569A1 (en) * | 2016-10-26 | 2019-09-19 | Astellas Pharma Inc. | Stable pharmaceutical composition |
WO2023129667A1 (fr) | 2021-12-30 | 2023-07-06 | Biomea Fusion, Inc. | Composés pyrazines utilisés comme inhibiteurs de flt3 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110025224A (ko) * | 2008-06-27 | 2011-03-09 | 아빌라 테라퓨틱스, 인크. | 헤테로아릴 화합물 및 이의 용도 |
NZ627709A (en) * | 2010-06-23 | 2014-12-24 | Hanmi Science Co Ltd | Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
RS55704B1 (sr) * | 2012-01-17 | 2017-07-31 | Astellas Pharma Inc | Jedinjenje pirazin karboksamida |
-
2015
- 2015-05-27 CN CN201580026409.3A patent/CN106456636A/zh active Pending
- 2015-05-27 MA MA039908A patent/MA39908A/fr unknown
- 2015-05-27 MX MX2016015551A patent/MX2016015551A/es unknown
- 2015-05-27 EA EA201692479A patent/EA201692479A1/ru unknown
- 2015-05-27 AU AU2015266552A patent/AU2015266552A1/en not_active Abandoned
- 2015-05-27 WO PCT/JP2015/065154 patent/WO2015182628A1/fr active Application Filing
- 2015-05-27 US US15/314,364 patent/US20170196859A1/en not_active Abandoned
- 2015-05-27 EP EP15799603.4A patent/EP3150206A1/fr not_active Withdrawn
- 2015-05-27 SG SG11201609837WA patent/SG11201609837WA/en unknown
- 2015-05-27 KR KR1020167033075A patent/KR20170005820A/ko unknown
- 2015-05-27 TW TW104116974A patent/TW201625254A/zh unknown
- 2015-05-27 JP JP2016523519A patent/JPWO2015182628A1/ja active Pending
- 2015-05-27 CA CA2949028A patent/CA2949028A1/fr not_active Abandoned
-
2016
- 2016-11-16 IL IL249010A patent/IL249010A0/en unknown
- 2016-11-21 PH PH12016502313A patent/PH12016502313A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12016502313A1 (en) | 2017-02-13 |
TW201625254A (zh) | 2016-07-16 |
SG11201609837WA (en) | 2016-12-29 |
US20170196859A1 (en) | 2017-07-13 |
IL249010A0 (en) | 2017-01-31 |
CA2949028A1 (fr) | 2015-12-03 |
WO2015182628A1 (fr) | 2015-12-03 |
EA201692479A1 (ru) | 2017-03-31 |
AU2015266552A1 (en) | 2016-12-01 |
EP3150206A1 (fr) | 2017-04-05 |
CN106456636A (zh) | 2017-02-22 |
KR20170005820A (ko) | 2017-01-16 |
MX2016015551A (es) | 2017-03-23 |
JPWO2015182628A1 (ja) | 2017-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501084A1 (en) | Heterocyclic compounds as immunomodulators | |
PH12018500899A1 (en) | Compositions and methods for inhibiting arginase activity | |
EA033343B1 (ru) | Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой | |
MX2019001125A (es) | Inhibidores de cinasa macrociclica. | |
PH12016501578A1 (en) | Pharmaceutical compounds | |
PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
PH12016501962A1 (en) | Macrocyclic pyridine derivatives | |
PH12016501963A1 (en) | Macrocyclic pyrimidine derivatives | |
PH12019502363A1 (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
MX2018000419A (es) | Derivados de amida sustituida que tienen actividad multimodal contra el dolor. | |
PH12016501527B1 (en) | Pharmaceutical composition comprising diamino heterocyclic carboxamide compound as active ingredient | |
PH12016502313A1 (en) | Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient | |
PT3279210T (pt) | Péptido com atividade anticancerígena, composição farmacêutica e composição de suplementos alimentares para prevenção e tratamento do cancro, ambos os quais contêm o mesmo ingrediente ativo | |
PH12017501334A1 (en) | 3,5-diaminopyrazole kinase inhibitors | |
MX2018007517A (es) | Compuestos triciclicos y composiciones como inhibidores de quinasa. | |
MX2018004774A (es) | Derivados de morfolina sustituidos que tienen actividad contra el dolor. | |
MX2017007648A (es) | Composicion farmaceutica que comprende compuesto biciclico de amida heterociclica aromatica que contiene nitrogeno como ingrediente activo. |